Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

New Ultrafast 5-Minute PCR Technology Faster Than Self-Diagnosis Kits

By LabMedica International staff writers
Posted on 24 Feb 2023

PCR technology which detects target nucleic acids by amplifying the DNA amount has witnessed significant progress in the life sciences field since it was first developed in 1984. More...

The molecular diagnostics technology achieved public familiarity during the COVID-19 pandemic, as PCR is capable of detecting nucleic acids that identify the COVID-19 virus. However, the technical nature of the PCR test makes it impossible for the results to be delivered before one to two hours due to its need for repeated temperature cycles (60~95℃). Now, a new ultrafast PCR technology uses photothermal nanomaterials to shorten the test time by 10-fold, as compared with the time taken by the existing test. The new method can be completed in five minutes and delivers a diagnostic performance that is similar to that of the existing test method.

Photothermal nanomaterials generate heat immediately upon light irradiation and rapidly increase in temperature, although the performance can be difficult to maintain due to their low stability. A research team at Korea Institute of Science and Technology (KIST) has developed a polymer composite that physically holds photothermal nanomaterials and can overcome their instability. By applying it to a PCR system, the team has developed a compact PCR system without a heat plate. Additionally, the researchers have implemented a multiplex diagnostic technology that detects several genes simultaneously, enabling it to distinguish several types of COVID-19 variants in a single reaction.

"Through additional research, we plan to miniaturize the developed ultrafast PCR technology this year, to develop a device that can be utilized anywhere," said Dr. Sang Kyung Kim, Director at the Center for Augmented Safety System with Intelligence, Sensing of the KIST. "While maintaining the strength of PCR as an accurate diagnostic method, we will increase its convenience, field applicability, and promptness, by which we expect that it will become a precision diagnostic device that can be used at primary local clinics, pharmacies, and even at home. In addition, PCR technology is a universal molecular diagnostic technology that can be applied to various diseases other than infectious diseases, so it will become more applicable."

Related Links:
KIST


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.